GlassScriptPhysician profile
Justin Allard
NPI 1164876991
$1,643.54
in general payments reported to CMS, 2019-2025
12 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $459 · 2023: $212 · 2024: $548 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $498.59 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $486.19 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intuitive Surgical, INC. | $324.72 | 2023-2025 | Da Vinci Surgical System |
| Depuy Synthes Sales INC. | $146.25 | 2024 | Matrixrib |
| Atricure, INC. | $32.05 | 2024 | |
| Aroa Biosurgery Incorporated | $31.94 | 2025 | |
| Access Pro Medical, LLC | $31.04 | 2025 | Matriderm |
| Smith+Nephew, INC. | $27.93 | 2025 | Renasys Go V2 Home, Pico, Renasys Touch |
| W. L. Gore & Associates, INC. | $21.67 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Solventum Corporation | $15.00 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Baxter Healthcare | $14.11 | 2024 | Tisseel |
| Acera Surgical, INC. | $14.05 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Allard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.